Print

Nanobac Pharmaceuticals Announces Sharpened Focus  
3/31/2006 12:46:12 PM

TAMPA, Fla.--(BUSINESS WIRE)--March 31, 2006--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") today announced a sharpened focus on developing safe and effective drug therapies for diseases where calcification, or "calcium deposits", is a dominant feature.
//-->